NCT03790254

Brief Summary

The aim of this review is to address clinical reliability, efficacy and safety of long-term treatment with oral D Mannose for the prevention of recurrent urinary tract infections (RUTIs) in females.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2018

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2018

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

December 26, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 31, 2018

Completed
Last Updated

December 31, 2018

Status Verified

December 1, 2018

Enrollment Period

9 years

First QC Date

December 26, 2018

Last Update Submit

December 28, 2018

Conditions

Keywords

recurrent urinary tract infectionsd mannose prophylaxisantibiotic prophylaxis

Outcome Measures

Primary Outcomes (1)

  • research literature data on d mannose for prevention and treatment of recurrent urinary tract infections.

    literature search of the Medline, Embase, and Cochrane Library databases

    January 2010-December 2018

Interventions

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Search strategy and selection criteria Only publications with the text and/or the abstract written in the English language were considered. Additional papers cited in the references of the search manuscripts were further examined. Articles not addressing topics of interest were excluded, and the full text of the remaining articles was examined. Our literature search identified 15 articles pertaining to the search terms (Word variations have been searched). Further analysis of these articles resulted in 11 clinical trials which were deemed relevant to our review. The retrieved studies were assessed for their relevance based on the title and abstracts. Finally, studies references were screened in order to identify eventually unknown studies.

You may qualify if:

  • recurrent urinary tract infections (RUTIs)

You may not qualify if:

  • Upper urinary tract infections, severe clinical symptoms, fever \> 37,5 with lumbar pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Urology Department Fondazione IRCCS Policlinico San Matteo

Pavia, 27100, Italy

Location

MeSH Terms

Conditions

Urinary Tract Infections

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Daniele Porru, MD

    Fondazione IRCCS Policlinico San Matteo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

December 26, 2018

First Posted

December 31, 2018

Study Start

January 1, 2010

Primary Completion

December 20, 2018

Study Completion

December 25, 2018

Last Updated

December 31, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share

Locations